Company / Interest Expense per Share
Rani Therapeutics Holdings, Inc. Interest Expense per Share History
FY2021-FY2025 · Annual data · Source: SEC filings
At a glance
Latest annual filing availableLatest Interest Expense per Share
$176.75
FY2025
5-year range
$0.01 / $199.37
FY2021-FY2025
Trend
-11.3%
vs FY2024
Sector context
Sector data unavailable
Latest sector comparison
What the data says
Increased from $23.86 to $176.75 over the past 3 years.
Based on SEC 10-K filings.
176.75 in FY2025 with a 3-year CAGR of +94.9%.
Increased from $23.86 to $176.75 over the past 3 years.
Interest Expense per Share over time
Growth rates
- 3-Year CAGR
- +94.9%
- 5-Year CAGR
- -
- 10-Year CAGR
- -
Key checks
Key Insights
- In FY2025, interest expense per share decreased 11.3% year-over-year.
Company context
Key Data Points
- Altman Z-Score -1.77 (distress zone, below 1.8 threshold)
- Low earnings quality (accrual-heavy earnings)
Data sourced from SEC EDGAR filings. Not investment advice.
Annual data
| Year | Interest Expense per ShareValue | YoY GrowthYoY |
|---|---|---|
| FY2025 | $176.75 | -11.3% |
| FY2024 | $199.37 | +735.7% |
| FY2022 | $23.86 | +375706.5% |
| FY2021 | $0.01 | - |
As of FY2025 · SEC 10-K · Updated Jun 28, 2026